Minoxidil

Generic Name: Minoxidil

Brand Names: Loniten, Minox, Regoxidine, Rogaine

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₅N_₅O

CAS Number: 38304-91-5

Unique Ingredient Identifier: 5965120SH1

Background: A potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure.

Indication: For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.

Associated Conditions: Androgenetic Alopecia (AGA), Severe, symptomatic Hypertension

Clinical Trials

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

Phase 3

Not yet recruiting

Conditions: Androgenetic Alopecia
Male Pattern Baldness

Interventions: Drug: Minoxidil
Drug: Placebo

First Posted Date: 2025-04-11

Last Posted Date: 2025-04-11

Lead Sponsor: Samson Clinical Operations Pty Ltd

Target Recruit Count: 132

Registration Number: NCT06924632

Various Procedural Treatment Options for Androgenetic Alopecia

Phase 2

Not yet recruiting

Conditions: Androgenetic Alopecia

Interventions: Drug: topical finasteride
Drug: Topical minoxidil

First Posted Date: 2025-02-13

Last Posted Date: 2025-02-13

Lead Sponsor: Sheikh Zayed Medical College

Target Recruit Count: 190

Registration Number: NCT06826001

Locations: 🇵🇰
Sheikh zayed Medical College and Hospital, Rahim Yar Khan, Punjab 644200, Rahim Yar Khan, Punjab, Pakistan

A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata

Early Phase 1

Completed

Conditions: Alopecia Areata

Interventions: Drug: sildenafil-loaded liposomes
Drug: minoxidil gel

First Posted Date: 2024-07-30

Last Posted Date: 2024-07-30

Lead Sponsor: Assiut University

Target Recruit Count: 28

Registration Number: NCT06527729

Locations: 🇪🇬
Faculty of Medicine, Assiut university, Assiut, Egypt

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Phase 3

Not yet recruiting

Conditions: Androgenetic Alopecia
Female Pattern Baldness
Male Pattern Baldness

Interventions: Dietary Supplement: DA-005
Drug: Topical minoxidil 5%
Drug: DA-002
Other: Placebo Topical Solution
Dietary Supplement: Placebo Oral Tablet

First Posted Date: 2024-07-15

Last Posted Date: 2024-12-19

Lead Sponsor: Applied Biology, Inc.

Target Recruit Count: 516

Registration Number: NCT06501924

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Phase 3

Withdrawn

Conditions: Androgenetic Alopecia
Female Pattern Baldness

Interventions: Drug: Topical minoxidil 5%
Dietary Supplement: Daniel Alain Probiotic Treatment for Androgenetic Alopecia

First Posted Date: 2024-07-03

Last Posted Date: 2024-10-15

Lead Sponsor: Applied Biology, Inc.

Registration Number: NCT06484881

Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss

Phase 1

Recruiting

Conditions: Dermatology
Female Pattern Baldness

Interventions: Drug: Topical minoxidil
Drug: Saline spray
Drug: Topical Vitamin D

First Posted Date: 2024-03-27

Last Posted Date: 2024-03-27

Lead Sponsor: Sohag University

Target Recruit Count: 45

Registration Number: NCT06333600

Locations: 🇪🇬
Facult of Medicine, Sohag Uniiversity, Sohag, Egypt

Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Not Applicable

Recruiting

Conditions: Androgenetic Alopecia

Interventions: Drug: 5% Minoxidil
Device: non-ablative fractional 1565nm

First Posted Date: 2024-01-23

Last Posted Date: 2024-01-23

Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Target Recruit Count: 135

Registration Number: NCT06218498

Locations: 🇨🇳
Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Not Applicable

Recruiting

Conditions: Androgenetic Alopecia

Interventions: Drug: 5% minoxidil
Procedure: microneedling
Procedure: Autologous Concentrated Growth Factor

First Posted Date: 2024-01-23

Last Posted Date: 2024-01-23

Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Target Recruit Count: 135

Registration Number: NCT06218394

Locations: 🇨🇳
Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China

Hair Regeneration in Androgenetic Alopecia

Not Applicable

Active, not recruiting

Conditions: Androgenetic Alopecia

Interventions: Other: Secretome from adipose-derived stem cells
Drug: Minoxidil Topical
Combination Product: Combination of minoxidil and secretome from adipose-derived stem cells

First Posted Date: 2023-10-04

Last Posted Date: 2023-10-10

Lead Sponsor: Dr. dr. Lili Legiawati, SpKK(K)

Target Recruit Count: 60

Registration Number: NCT06066827

Locations: 🇮🇩
RSUP Nasional Cipto Mangunkusumo, Jakarta Pusat, DKI Jakarta, Indonesia
🇮🇩
Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia

Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Phase 4

Active, not recruiting

Conditions: Androgenetic Alopecia

Interventions: Combination Product: Platelet-Rich Plasma and Topical 5% Minoxidil
Drug: Topical 5% Minoxidil

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: Indonesia University

Target Recruit Count: 36

Registration Number: NCT06043349

Locations: 🇮🇩
Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, Greater Jakarta Area, Indonesia

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy